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Atherosclerosis is a chronic inflammatory disease of the blood vessels, characterized by
atherosclerotic lesion formation. Vascular Smooth Muscle Cells (VSMC), macrophages
(M8), and dendritic cells (DC) play a crucial role in vascular inflammation
and atherosclerosis. Interferon (IFN)α, IFNγ, and Toll-like receptor (TLR)4 activate
pro-inflammatory gene expression and are pro-atherogenic. Gene expression regulation
of many pro-inflammatory genes has shown to rely on Signal Integration (SI)
between IFNs and TLR4 through combinatorial actions of the Signal Transducer
and Activator of Transcription (STAT)1 complexes ISGF3 and γ-activated factor
(GAF), and Nuclear Factor-κB (NFκB). Thus, IFN pre-treatment (“priming”) followed
by LPS stimulation leads to enhanced transcriptional responses as compared to
the individual stimuli. To characterize the mechanism of priming-induced IFNα +
LPS- and IFNγ + LPS-dependent SI in vascular cells as compared to immune cells,
we performed a comprehensive genome-wide analysis of mouse VSMC, M8, and
DC in response to IFNα, IFNγ, and/or LPS. Thus, we identified IFNα + LPS or
IFNγ + LPS induced genes commonly expressed in these cell types that bound
STAT1 and p65 at comparable γ-activated sequence (GAS), Interferon-stimulated
response element (ISRE), or NFκB sites in promoter proximal and distal regions.
Comparison of the relatively high number of overlapping ISRE sites in these genes
unraveled a novel role of ISGF3 and possibly STAT1/IRF9 in IFNγ responses. In
addition, similar STAT1-p65 co-binding modes were detected for IFNα + LPS and
IFNγ + LPS up-regulated genes, which involved recruitment of STAT1 complexes
preceding p65 to closely located GAS/NFκB or ISRE/NFκB composite sites already
upon IFNα or IFNγ treatment. This STAT1-p65 co-binding significantly increased after
subsequent LPS exposure and correlated with histone acetylation, PolII recruitment,
and amplified target gene transcription in a STAT1-p65 co-bound dependent manner.
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Thus, co-binding of STAT1-containing transcription factor complexes and NFκB,
activated by IFN-I or IFN-II together with LPS, provides a platform for robust
transcriptional activation of pro-inflammatory genes. Moreover, our data offer an
explanation for the comparable effects of IFNα or IFNγ priming on TLR4-induced
activation in vascular and immune cells, with important implications in atherosclerosis.
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INTRODUCTION
Atherosclerosis is a chronic inflammatory disease of the
blood vessels, characterized by atherosclerotic lesion formation.
Early onset of atherosclerosis is represented by recruitment
of blood leukocytes to the injured vascular endothelium
and altered contractility of Vascular Smooth Muscle Cells
(VSMC) modulated by multiple inflammatory mediators (1).
Accordingly, pro-inflammatory pathways activated by Toll-like
receptors (TLRs), and Interferons (IFNs) have been identified
as key components of atherogenesis (2–4). Type I (IFN-
I; IFNα), and II (IFN-II; IFNγ) IFNs both induce IFN-
stimulated gene (ISG) expression through Janus kinase (JAK)-
dependent phosphorylation of Signal Transducer and Activator
of Transcription (STAT)1. STAT1 homodimers, known as γ-
activated factor (GAF), activate transcription in response to both
IFN types by direct binding to IFN-II activation site γ-activated
sequence (GAS)-containing genes. Association of Interferon
Regulatory Factor (IRF)9 with STAT1–STAT2 heterodimers
[known as Interferon-stimulated gene factor 3 (ISGF3)] in
response to IFN-I, redirects these complexes to a distinct group
of target genes harboring the Interferon-stimulated response
element (ISRE) (5, 6). Limited evidence exists for a role of ISGF3
in IFN-II responses of ISRE-containing genes. Likewise, for a
restricted number of ISGs, a non-canonical STAT1/IRF9 complex
was shown to control IFNγ-responsiveness (7–9). The partially
overlapping and differential activation of transcription factor
complexes and regulation of target gene expression by IFN-I and
IFN-II, may be a consequence of the biological similarities and
differences of these two IFN types.
TLR4 ligation results in the prompt activation of multiple
transcription factors, including members of the Nuclear Factor-
κB (NFκB) and IRF families (10, 11). These factors rapidly
induce the expression of hundreds of genes that amplify the
initial inflammatory response, exert antimicrobial activities and
initiate the development of acquired immunity. Several of the
cytokines that are up-regulated in the initial wave of immediate
early gene expression function in feed forward transcriptional
loops—particularly important examples being IFN-I, which
Abbreviations: ChIP, Chromatin Immunoprecipitation; Co-IP, Co-
immunoprecipitation; DC, Dendritic cells; EC, Endothelial cells; GAF, γ-activated
factor; GO, Gene ontology; IFN, Interferon; IRF, Interferon Regulatory
Factor; ISG, IFN-stimulated gene; ISGF3, Interferon-stimulated gene factor
3; ISRE, Interferon-stimulated response element; JAK, Janus kinase; LPS,
Lipopolysaccharide; M8, Macrophages; NFκB, Nuclear Factor-κB; PolII, RNA
polymerase II; ROS, Reactive oxygen species; SI, Signal Integration; STAT, Signal
Transducer and Activator of Transcription; TNF, Tumor necrosis factor; TLR,
Toll-like receptor; VSMC, Vascular Smooth Muscle Cells.
induce a secondary wave of STAT1- and STAT2-dependent gene
expression, and Tumor necrosis factor (TNF) which sustains
NFκB signaling.
Gene expression regulation of many pro-inflammatory genes
has shown to rely on Signal Integration (SI) between IFNs and
TLR4 through combinatorial actions of the STAT1-containing
complexes ISGF3 and GAF with NFκB. For example, previous
analyses of the murine Nos2 promoter revealed an IFN response
region (containing GAS and ISRE sites) and binding sites for
NFκB (12). Indeed, sequential and cooperative contributions
of NFκB preceding ISGF3 were shown to be involved in the
transcriptional induction of the Nos2 gene in macrophages
(M8) infected with the intracellular bacterial pathogen Listeria
monocytogenes (13). The Nos2 gene reflects a larger group of
genes, co-regulated by TLR4 and IFNs (14, 15). On the other
hand, the profound effects of IFNγ pre-treatment (“priming”) on
TLR4-induced M8 activation have also long been recognized.
In this respect, SI between IFNγ and lipopolysaccharide (LPS)
relies on combinatorial actions of STAT1 with NFκB and IRFs on
ISRE/NFκB or GAS/NFκB binding sites, which leads to enhanced
transcriptional regulation of many pro-inflammatory genes.
Together, this coordinates the antimicrobial and inflammatory
responses in M8, but also in dendritic cells (DC) (16–
19). Recently, we characterized the role of STAT1 in the
transcriptional response pathways involved in the interaction
between IFN-II and TLR4 signaling in endothelial cells (EC) and
VSMC (20). Promoter analysis of the genes encoding multiple
chemokines, adhesion molecules and antiviral and antibacterial
response proteins, predicted that cooperation between NFκB and
STAT1 is involved in the amplified transcriptional regulation
of responses to IFN-II and LPS. The synergistic interactions
between IFNγ and TLR4 also resulted in increased T-cell
migration and impaired aortic contractility in a STAT1-
dependent manner (20). Interestingly, expression of the Nos2
gene in M8 in response to IFNα/LPS behaved similar as after
IFNγ/LPS (21), reflecting the existing overlap in activation
mechanisms between the different types of IFN. However, the
mechanistic role of SI between IFN-I and TLR4, in the context
of “priming,” in vascular and immune cell has not been studied in
much detail.
To characterize the mechanism of priming-induced IFNα +
LPS- and IFNγ+ LPS-dependent SI in vascular cells as compared
to immune cells, we performed a comprehensive genome-
wide analysis of VSMC, M8, and DC in response to IFNα,
IFNγ, and/or LPS. Thus, through increased histone acetylation
and RNA polymerase II (PolII) recruitment co-binding of
transcription factor complexes activated by IFN-I or IFN-II
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together with LPS, including GAF, ISGF3, STAT1/IRF9, and p65-
p50 heterodimers provide a platform for robust transcriptional
activation of pro-inflammatory genes. Moreover, our data offer
an explanation for the comparable effects of IFNα or IFNγ
priming on TLR4-induced activation in vascular and immune
cells, with important implications in atherosclerosis.
MATERIALS AND METHODS
VSMC, M8, and DC Isolation
WT mice (strain background C57BL/6) were obtained from
Charles River Laboratories. STAT1−/− mice (strain background
C57BL/6) (22) were kindly provided by Thomas Decker
(Department of Microbiology, Immunobiology and Genetics,
University of Vienna). Before any manipulations, animals were
euthanized by cervical dislocation under isoflurane anesthesia.
Primary VSMC were isolated from WT and STAT1−/− mice
aortas by enzymatic digestion (23). Briefly, aortas were dissected
out and carefully cleaned from remnant fat and connecting tissue
and cut into rings. Next, tissue was incubated with digestion mix
consisting of DMEM [Thermo Fisher Scientific (TFS), 11960044]
supplemented with 0.744 U/ml Elastase I (Sigma Aldrich, E1250),
1 mg/ml Collagenase II (Sigma Aldrich, 1148090) and 1 mg/ml
soybean trypsin inhibitor (TFS, 17075029) for 1 h at 37◦C.
After digestion the cell suspension was passed through 100µm
cell strainer and left undisturbed for 1 week. Examination of
marker gene (α-actin, smoothelin, calponin) expression by RT-
PCR was used to assess VSMC cell phenotype. Freshly isolated
femur and tibia form WT mice were cleaned from remnant
muscle tissue by scrapping. Both ends of the bones were cut
and bone-marrow was flushed and centrifuged for 5min, 1,500
rpm. The cell pellet was incubated in ACK buffer (pH 7.2–
7.4) in order to lyse red blood cells. Monocytes were purified
through a Ficoll-Paque gradient (GE Healthcare, 17-1440).
Afterwards primary M8 were differentiated in DMEM medium
[Thermo Fisher Scientific (TFS), 11960044] supplemented with
30% L929 conditioned medium (containing M-CSF), 15%
FBS (Sigma-Aldrich, F7524) and 1:100 antibiotic/antimycotic
solution (Sigma-Aldrich, A5955) for 5 days (24). Similarly,
primary DC were differentiated from bone-marrow using a
solution containing RPMI1640 medium (Sigma-Aldrich, R5886),
200 U/ml rmGM-CSF (PeproTech, 315–03), 10% FBS (Sigma-
Aldrich, F7524), 1:100 antibiotic/antimycotic solution (Sigma-
Aldrich, A5955), 2mM L-glutamine (Sigma-Aldrich, 67513),
and 50µM β-ME (TFS, 31350-010) for 6 days according to
a modified Lutz et al. protocol (25). Purity of M8 and DC
populations was assessed by flow cytometry, with F4/80 and
CD11b, CD11c markers, respectively. Experimental procedures
performed in this study, encompassing sacrificing mice for
bone marrow or tissue isolation, did not require any medical
ethical approval in accordance with the local legislation and
institutional requirements.
Cell Culture and Treatment
WT and STAT1−/− VSMC were cultured in DMEM complete
medium (TFS, 11960044) supplemented with 10% FBS (TFS,
10500-064), 1:100 L-glutamine (BioWest, X0550), and 1:100
antibiotic/antimycotic solution (Sigma-Aldrich, A5955). On
the day before treatment, complete medium was exchanged
onto 2% FBS containing starving medium. Differentiated M8
and DC were immediately placed in serum free medium
(TFS, 12065074) or 2% FBS (Sigma-Aldrich, F7524) containing
RMPI1640 (Sigma-Aldrich, R5886) supplemented with 1:100
antibiotic/antimycotic solution (Sigma-Aldrich, A5955) and
50µM β-ME (TFS, 31350-010), respectively, for 24 h. Afterwards,
cells were treated with single stimulus as follows: 1,000 U/ml
of IFNα (Merck Millipore, IF009) or 10 ng/ml of IFNγ (TFS,
PMC4031) for 8 h; 10 ng/ml (M8 and DC)/1µg/ml (VSMC)
of LPS (Sigma-Aldrich, L4391) for 4 h. To further study the
effect of IFNs pre-treatment on LPS signaling the cells were
first treated with IFNα or IFNγ, after 4 h LPS was added to the
same cell culture plates for an additional 4 h, what resulted in
a total of 8 h treatment with IFNs and 4 h treatment with LPS,
at concentrations listed above. Described treatment strategy was
applied in both RNA-seq and ChIP-seq experiments performed
in this study.
Gene Ontology (GO)
Protein ANalysis THrough Evolutionary Relationships
(PANTHER) resource (26) was applied to identify statistically
overrepresented GO terms for mapped lists of commonly
up-regulated [Fold Change (FC) > 2] genes in VSMC, M8, and
DC after combined treatment with IFNα + LPS (579 genes)
and IFNγ + LPS (536 genes), using GO Biological Process
Complete annotation data set. GO terms subjected for further
comparison between the gene lists were selected as representative
terms related to biological functions involved in immune,
inflammatory, defense and stress response. Only GO terms with
p-value of<0.05 were considered as significantly enriched.
Promoter Analysis
Over-represented conserved Transcription Factor Binding Sites
(TFBS) for STAT1 and NFκB were screened in the regulatory
regions of commonly up-regulated (FC > 2) genes in VSMC,
M8 and DC after combined treatment with IFNα + LPS (579
genes) and IFNγ + LPS (536 genes) using pSCAN webserver
(27). JASPAR Profiles for: GAS—MA0137.2, MA0137.3, ISRE—
MA0652.1, MA0137.1, MA0.517.1, and NFκB—MA0105.1,
MA0105.3. TFBS were analyzed in the region of −950/+50 bp
to the nearest gene transcription start site. Applied threshold
of matrix similarity score for potential GAS/ISRE and NFκB
binding site was ≥0.85 and ≥0.90, respectively.
Western Blot
Protein extracts from primary WT VSMC were prepared using
Radio Immuno Precipitation Assay (RIPA) buffer (50mM Tris-
HCl, pH = 8.0 (Invitrogen, 15568025), 150mM NaCl (Sigma-
Aldrich, S9888), 1% Nonidet-40 (Bio-Shop, NON505), 0.5%
sodium deoxycholate (Bio-Shop, DCA333), 0.1% SDS (Bio-
Shop, SDS001), 1% protease inhibitor cocktail (Sigma-Aldrich,
P8340), 1% EDTA (TFS, 15575-038), 0.1% PMSF (Sigma-
Aldrich, 93482), and stored at −80◦C. Protein concentrations
were quantified using Bicinchoninic Acid (BCA) kit (Pierce,
23227). Sixty microgram of protein was heated in Bolt LDS
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buffer (Invitrogen, B0008) in 70◦C for 10min and loaded on
Blot 4–12% Bis-Tris Plus Gels (Invitrogen, NW04120BOX),
electrophoresed and transferred to PVDF membrane (GVS Nort
America, 1231325). Western blot experiments were performed
using SNAP ID Protein Detection System (Merck Millipore).
Membranes were blocked either with 0.125% non-fat dry milk or
with 1% BSA in TBS-Tween (TBS-T) and incubated with primary
antibodies: tSTAT1 (CST, 14994, D1K9Y) 1:500, pSTAT1 (CST,
7649, D4A7) 1:500, tSTAT2 (CST, 72604, D9J7L) 1:400, pSTAT2
(Merck Millipore, 07-224) 1:500, IRF1 (CST, 8478, D5E4) 1:300,
IRF9 (CST, 28845, D9I5H) 1:500, tp65 (CST, 6956, L8F6)
1:500, tubulin (Merck Millipore, 04-1117, EP1332Y) 1:2,000
and next with secondary HRP-conjugated antibodies: anti-rabbit
(Sigma-Aldrich, A9169) 1:20,000, anti-mouse (Sigma-Aldrich,
A9044) 1:20,000. Antibody-antigen complexes were visualized by
enhanced chemiluminescence (ECL) using Luminata Forte HRP
Substrate (Merck Millipore, WBLUF0500) and detected with
G:Box System (Syngene). Image Studio Lite software (LI-COR
Biosciences) was used for western blot quantification.
Co-immunoprecipitation (Co-IP)
VSMC WT cells were lysed for 30min in co-IP buffer
[1% NP-40 (Bio-Shop, NON505), 150mM NaCl (Sigma-
Aldrich, S9888), 1mM EDTA (TFS, 15575-038), 50mM Tris
HCl pH 7.5 (Invitrogen, 15567027) 10% Glycerol (Bio-Shop,
GLY001)] supplemented with protease inhibitors. Cell lysates
were immunoprecipitated with IRF1 (CST, 8478, D5E4) and
IRF9 (CST, 28845, D9I5H) antibodies overnight at 4◦C.
Immunocomplexes were isolated with Dynabeads Protein A/G
[TFS, 10008D(A), 10009D(G)] saturated with 1% BSA (Sigma-
Aldrich, A3059), by gentle rocking for 3 h at . Beads were washed
3 times with ice-cold co-IP buffer and once with Tris-EDTA
buffer. Next bound proteins were retrieved by boiling in Bolt LDS
buffer (Invitrogen, B0008) for 10min. Immunocomplexes were
analyzed by Western blot (described in Materials and Methods
section, Western blot) with tSTAT1 (CST, 14994, D1K9Y) 1:500
and tSTAT2 (CST, 72604, D9J7L) 1:400.
RNA-seq Experimental Procedure
Total RNA from primary WT VSMC, WT M8, and WT DC
treated as described above was isolated using GeneMATRIX
Universal RNA Purification Kit (EURx, E3598). RNA-seq
libraries were prepared from at least three biological replicates
using a TruSeq RNA Library Preparation kit (Illumina, RS-
122) according to the manufacturer’s protocol. Libraries were
quantified by Qubit fluorometer (TFS) and the quality was
assessed with Agilent High Sensitivity DNA kit (Agilent
Technologies, 5067-4626). Libraries were sequenced with
Illumina HiScanSQ sequencer. To validate the quality of RNA-
seq dataset, primary WT VSMC, WT M8, and WT DC were
treated as described previously and 1 µg of RNA was used
to synthetize complementary DNA with RevertAid Reverse
Transcriptase (TFS, EP0441). Cxcl9, Cxcl10, Ccl5, Nos2, Gbp6
transcripts were quantified using Maxima SYBR Green/ROX
qPCR Master Mix (TFS, K0223) and CFX Connect Thermal
Cycler System (Bio-Rad). Target gene levels were normalized
to β-actin (ACTB) and quantified as described elsewhere (28)
(described in Results section; data not shown).
Chromatin Immunoprecipitation (ChIP)-seq
Experimental Procedure
ChIP was carried out as previously described (29), with
minor modifications. Briefly, primary WT and STAT1−/−
VSMC treated as described above were double-cross-linked with
0.5M DSG (Sigma-Aldrich, 80424) for 45min followed by 1%
formaldehyde (TFS, 28906) for 10min. Glycine (Sigma-Aldrich,
G7126) was added for 10min in 125mM final concentration to
stop cross-linking process. After fixation, nuclei were isolated
by addition of ChIP Lysis Buffer (1% Triton X-100 (Bio-Shop,
TRX777), 0.1% SDS (Bio-Shop, SDS001), 150mM NaCl (Sigma-
Aldrich, S9888), 1mM EDTA (TFS, 15575-038), and 20mM
Tris, pH 8.0 (TFS, 15568-025). Chromatin was sonicated with
Diagenode Bioruptor to generate fragments of 100–2,000 bp and
immunoprecipitated with tSTAT1 (Santa Cruz, sc-346), pSTAT1
(CST, 7649, D4A7), tSTAT2 (CST, 72604, D9J7L), pSTAT2
(Merck Millipore, 07-224), IRF1 (CST, 8478, D5E4), IRF9 (CST,
28845, D9I5H), tp65 (CST, 6956, L8F6), RNA Polymerase II
(Merck Millipore, 05-623, CTD4H8), Acetyl-Histone H3 (Lys27)
(CST, 8173, D5E4), and Tri-Methyl-Histone H3 (Lys27) (CST,
9733, C36B11) antibodies. Following overnight incubation at
4◦C,Dynabeads Protein A/G [TFS, 10008D(A), 10009D(G)] were
added and incubated for 6 h at 4◦C with rotation. Beads were
washed at 4◦C. DNA-protein complexes were eluted with Elution
Buffer (1%SDS (Bio-Shop, SDS001), 0.1M NaHCO3 (Sigma-
Aldrich, S5761), and de-cross-linked with 0.2M NaCl (Sigma-
Aldrich, S9888) at 65◦C. DNA was purified with MinElute
PCR Purification kit (Qiagen, 28006) and quantified with Qubit
fluorometer (TFS). ChIP-seq libraries were prepared from two
biological replicates (for tSTAT1 and tp65 IPs) using TruSeq
ChIP Library Preparation kit (Illumina, IP-202) according to the
manufacturer’s instructions. Libraries were quantified by Qubit
fluorometer (TFS) and the quality was assessed with Agilent High
Sensitivity DNA kit (Agilent Technologies, 5067-4626). Libraries
were sequenced with Illumina HiSeq 2500 sequencer. Quality
of ChIP-seq dataset was validated by ChIP-PCR experiments
for selected STAT1 and p65 target genes (described in Results
section; data not shown). All presented ChIP-PCR assays
were performed using biological duplicates with primers listed
in Table S2 (Supplementary Material). Statistical significance
was estimated by two-way ANOVA and unpaired two-tailed
student T-test.
RNA-seq Data Analysis
RNA-seq raw sequence reads analysis was performed using
Strand NGS software. After pre-alignment quality control (QC),
alignment to the mouse mm10 (GRCm38) genome assembly was
carried out using internal Strand NGS aligner which follows the
Burrows-Wheeler Alignment (BWA) approach. All aligned reads
were normalized using DESeq package. The data of the RNA-
seq can be found at the NCBI GEO DataSets, with the accession
number GSE120807. To determine differentially expressed genes
(FC≥ 2: up-regulated) gene lists were first filtered based on their
normalized signal intensity values, with lower cut-off value>8.
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FC was calculated for these genes across different conditions and
the resulting lists of up-regulated genes were used for the further
downstream analysis. 18 lists (3 cell types× 6 conditions: control,
IFNα, IFNγ, LPS, IFNα + LPS, IFNγ + LPS) of differentially
expressed genes were compared and visualized using BioVenn
diagram tool (30). Heatmaps presenting log2 transformed FC
values for commonly up-regulated genes in VSMC, M8 and DC
after combined treatment with IFNα+LPS (579 genes) and IFNγ
+ LPS (536 genes) across control, IFNα, IFNγ, LPS, IFNα +
LPS and IFNγ + LPS treatment conditions were generated using
GraphPad Prism v.7 software.
ChIP-seq Data Analysis
The primary analysis of ChIP-seq raw sequence reads was
carried out using ChIP-seq analysis command line pipeline
(31). Sequence reads were aligned to the mouse mm10
(GRCm38) genome assembly using the BWA tool (v0.7.10)
(32), and bam files were created by SAMTools (v0.1.19)
(32). Following converting mapped reads (bam files) by
makeTagDirectory (HOMER v4.2 Hypergeometric Optimization
of Motif EnRichment (33) to become accessible by the further
HOMER tools, genome coverage (bedgraph) files were created by
makeUCSCfile.pl (HOMER) (33) and converted to tiled data files
(tdfs) by IGVtools (34). Peaks were predicted byMACS2 (v2.0.10)
(q-value ≤ 0.01) (35), and artifacts were removed according
to the blacklist of ENCODE (36). Intersections, subtractions,
and merging of the predicted peaks (bed files) were made with
BedTools (v2.23.0) (37). Tdf and bed files were visualized and
genomic snapshots were taken with IGV2.3 (38). The closest
gene for each peak was identified by annotatePeaks.pl (HOMER).
The identification of DNA motifs was carried out in two steps.
First, scanMotifGenomeWide.pl (HOMER) was used to identify
all of the motifs genome-wide, specified by the publicly available
motif files. Second, we determined the intersection between
the identified motifs and peaks using intersectBed (bedtools).
Sequencing data were submitted to NCBI GEO DataSets under
accession number GSE120806.
RD (Read Distribution) Plot Preparation
For clustering, occupancy values (expressed as Reads Per
Kilobase Million, RPKM) were calculated for all STAT1 and p65
peaks. The peaks were clustered using k-means clustering (n =
10) based on the binding pattern of STAT1 and p65 in 6 samples
(12 ChIP-seq data sets in total). Normalized tag counts for RD
histograms were generated by HOMER and then visualized by
Java TreeView.
Peak Distribution Plot (Histogram)
Preparation
Distances between summits of STAT1 and the closest p65
peaks summits were calculated using Phyton. Histograms were
generated by annotatePeaks.pl from HOMER (with option-size
2,000 and -hist 25) and visualized by R using package ggplot2.
Integrative RNA-seq and ChIP-seq Analysis
GAS, ISRE and NFκB-p65 consensus motifs from HOMER
database (GAS—motif273, ISRE—motif140, NFκB—motif208;
motif logos in Supplementary Material, Figure S1) were re-
mapped to the called peak regions in STAT1 and p65 ChIP-seq
experiments, after treatment with IFNα + LPS and IFNγ + LPS
in VSMC. Next, list of 579 and 536 up-regulated commonly
expressed genes in vascular and immune cells treated with IFNα
+ LPS and IFNγ + LPS, respectively, identified from RNA-seq
experiment, were overlapped with the lists of re-mapped motifs
regions. The lists of annotated genes containing re-mapped
GAS, ISRE and NFκB motifs were initially filtered according to
motif distance from the closest annotated gene TSS (–/+100 kb)
and according to Motif Score Threshold (MST) (GAS—MST
6, ISRE—MST 6, NFκB—MST 7). Distribution of consensus
GAS, ISRE, and NFκB binding sites occupied by STAT1 and p65
across the genome was classified into seven categories of genomic
locations: promoter/TSS (−1 kb to+100 bp), introns, intergenic,
exon, 5′ UTR, 3′ UTR, and TTS. Re-mapped motifs distribution
was plotted by the percentage of total number of occupied GAS,
ISRE and NFκB binding sites under treatment with IFNα + LPS
or IFNγ+ LPS.
RESULTS
Commonly IFNα + LPS and IFNγ + LPS
Regulated Genes Unravel Mechanistic and
Functional Overlap of Priming-induced SI
To characterize themechanism of priming-induced IFNα+ LPS-
and IFNγ + LPS-dependent SI in vascular cells as compared
to immune cells, we compared genome-wide transcriptional
responses of VSMC, M8, and DC in response to IFNα (8 h),
IFNγ (8 h), or LPS (4 h) alone, or after combined treatment (IFNα
8 h+ LPS 4 h; IFNγ 8 h+ LPS 4 h) using RNA-seq. Consequently,
579 genes were commonly up-regulated in VSMC, M8, and
DC after combined treatment with IFNα + LPS (Figure 1A).
Likewise, 536 genes were commonly expressed after combined
treatment with IFNγ +L PS (Figure 1A). The complete lists of
up-regulated genes in response to IFNα, IFNγ, or LPS alone,
or after combined treatments in each cell type are shown in
Table S1. To validate the quality of our RNA-seq dataset, the
expression of a number of these genes, including Cxcl9, Cxcl10,
Ccl5, Nos2, Gbp6 was additionally confirmed by RT-PCR (data
not shown).
Heatmaps presenting the expression pattern of the commonly
579 IFNα + LPS and 536 IFNγ + LPS regulated genes in
VSMC, illustrate the potential effect of SI after combined
treatment with IFNα + LPS or IFNγ + LPS as compared
to the single stimuli (Figure 1B). Increasing brightness of red
color in the heatmap reflects increasing gene expression levels,
which in general are visibly higher after combined treatment
with IFNα + LPS and IFNγ + LPS in comparison to single
stimuli. After comparing the overall range and distribution
of the common gene expression after single or combined
stimulation (Figure 1C), in VSMC the effect of SI was clearly
visible in the presented box plot. The median gene expression
after combined treatment with IFNα + LPS and IFNγ +
LPS was higher in comparison to single treatments with IFNs
or LPS (Figure 1C). Tables 1A,B offer insight in the top-30
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FIGURE 1 | Mechanistic and functional characteristics of common gene expression between VSMC and M8, DC in response to IFNα + LPS and IFNγ + LPS.
(A) Venn diagrams based on RNA-seq results showing intersection between lists of up-regulated (FC > 2) genes in VSMC, M8, and DC after combined stimulation
with IFNα (8 h) + LPS (4 h) and IFNγ (8 h) + LPS (4 h). The gene lists for these Venn diagrams are shown in Table S1. Common 579 IFNα + LPS and 536 IFNγ +
LPS-induced genes between three cell types were highlighted by violet frames. (B) Heatmap plots depicting expression pattern of commonly up-regulated, 579 IFNα
(8 h) +LPS (4 h)- and 536 IFNγ (8 h) + LPS (4 h)-induced genes in VSMC, resulting from RNA-seq. Three main columns on each heatmap represent one particular
treatment condition [IFNα (8 h), IFNγ (8h), LPS (4 h), IFNα (8 h) + LPS (4 h), or IFNγ (8 h) + LPS (4 h)]. Increasing brightness of red color indicates a higher gene
expression level (gene expression is presented as log2 FC in comparison to control). (C) Box-plot representation of gene expression distribution for commonly
up-regulated genes by IFNα (8 h) + LPS (4 h) and IFNγ (8 h) + LPS (4 h) resulting from RNA-seq (gene expression is presented as log2 FC in comparison to control) in
VSMC. The line within each box represents the median and the lower and upper boundaries of each box indicate first and third quartiles, respectively. (D) Comparison
of commonly up-regulated genes by IFNα (8h) + LPS (4 h) and IFNγ (8 h) + LPS (4 h) from RNA-seq, showing 64.21% overlap between the gene lists. (E) GO analysis
of commonly up-regulated genes by IFNα (8 h) + LPS (4 h) and IFNγ (8 h) + LPS (4 h) (RNA-seq) revealed a strong enrichment for terms reflecting pro-inflammatory
and pro-atherogenic biological functions. P-value < 0.05. (F) Venn diagram distribution of promoter located (−950/+50 bp) GAS, ISRE, and NFκB binding sites
among commonly up-regulated genes by IFNα (8 h) + LPS (4 h) and IFNγ (8 h) + LPS(4 h) from RNA-seq experiment.
of these commonly up-regulated genes and illustrate the way
they respond to IFNα + LPS and IFNγ + LPS in VSMC
as compared to the single stimuli. The genes affected by SI
(reflected by increased gene expression after combined treatment
with IFNα + LPS or IFNγ + LPS vs. the sum of the single
treatments; see Materials and Methods) are marked with an
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TABLE 1A | Representative top-30 genes commonly up-regulated (FC > 2) by IFNα + LPS in VSMC, M8, and DC, reflecting SI between IFNα and LPS in VSMC.
No. IFNα + LPS induced
common genes
VSMC Binding site
IFNα LPS IFNα + LPS GAS ISRE NFκB
1 F830016B08Rik* 196.8 6.4 345.9 • • –
2 Ifi44 356.3 4.4 343.7 – • –
3 Cxcl10* 75.9 4.6 312.1 • • •
4 BC023105* 187.1 19.9 289.2 – – –
5 Nos2* 4.9 90.9 287.1 • • •
6 Gm4955* 209.5 5.4 260.2 – – –
7 Gm15725 294.6 2.9 259.8 – – –
8 Iigp1* 179.7 9.2 242.3 • • –
9 Gm4951* 178.6 6.9 233.4 • • –
10 Gbp9* 78.8 22.9 215.9 – • •
11 Gbp11* 62.1 13.6 196.5 • • –
12 Apod 213.7 2.2 194.9 – • •
13 Gm4841* 99.8 9.0 181.4 • • –
14 Gbp4* 36.4 16.4 162.0 • • •
15 Gm14446 164.5 1.8 157.8 – – –
16 Mx1* 128.8 3.3 155.9 – • •
17 Ifit1* 113.3 11.1 153.6 – • –
18 Gm12250* 94.8 3.6 142.3 • • –
19 Gm4902* 126.5 3.8 139.3 – – –
20 Tnfsf10* 35.8 3.2 128.9 • • •
21 Usp18* 96.3 8.9 127.5 – • •
22 Gbp1* 91.7 17.5 125.5 – • –
23 Gbp6* 36.9 23.5 117.2 • • •
24 Gbp10* 35.6 21.1 115.2 – • •
25 Ch25h* 3.5 19.6 112.6 • • •
26 Tgtp2 114.2 2.6 110.7 • • –
27 Gm6904* 94.9 2.6 107.8 – • –
28 Zbp1* 95.5 5.8 106.3 • • •
29 Saa3* 5.1 66.6 105.7 • – •
30 Phf11* 100.2 3.2 105.7 – – –
Gene expression levels were presented as FC relative to control in VSMCs. Signal Integrated genes (FC IFNα + LPS > FC IFNα + FC LPS) were marked by an asterisk (*). Overlapping
genes between IFNα + LPS- and IFNγ + LPS-induced commonly up-regulated genes (Table 1B) were color-coded by blue. Presence of GAS, ISRE, or NFκB binding sites in the
promoters of listed genes was indicated by a dot (•).
asterisk (Tables 1A,B). Strikingly, significant overlap could be
observed between commonly up-regulated genes in response to
IFNα + LPS and IFNγ + LPS. Indeed, the Venn diagram in
Figure 1D shows 64.21% overlap between the 579 IFNα +LPS
and 536 IFNγ+ LPS commonly up-regulated genes (Figure 1D).
Moreover, GO analysis of these 579 IFNα + LPS and 536
IFNγ + LPS commonly up-regulated genes revealed significant
enrichment in overlapping terms connected to stress, immune
and inflammatory response, response to cytokine, regulation
of cell proliferation and migration, regulation of cell adhesion
and chemotaxis, cell death and apoptotic process, response to
lipid, and reactive oxygen species (ROS) metabolic process,
all reflecting pro-inflammatory and pro-atherogenic biological
functions. This also confirms the existence of functional overlap
between vascular and immune cells, mediated by the interaction
of both IFNs with LPS, which results in the execution of
cell type-common biological responses (Figure 1E).
On the same lists of IFNα + LPS and IFNγ + LPS commonly
up-regulated genes we also performed in silico promoter analysis,
for the presence of ISRE, STAT, or NFκB binding sites in
the proximal promoter (−950 to +100 bp). The predicted
representation of individual or combined GAS, ISRE, or NFκB
binding sites is depicted in Figure 1F. Most of the genes
contained either single GAS sites (89 IFNα + LPS genes and 85
IFNγ + LPS genes) or rather combinations of potential GAS-
ISRE (98 IFNα + LPS genes and 91 IFNγ + LPS genes), GAS-
NFκB (68 IFNα + LPS genes and 66 IFNγ + LPS genes), ISRE-
NFκB (22 IFNα + LPS genes and 17 IFNγ+LPS genes), or
GAS-ISRE-NFκB (92 IFNα + LPS genes and 88 IFNγ + LPS
genes) binding sites. Together this suggested that a common SI
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TABLE 1B | Representative top-30 genes commonly up-regulated (FC > 2) by IFNγ + LPS in VSMC, M8, and DC, reflecting SI between IFNγ and LPS in VSMC.
No. IFNγ + LPS induced
common genes
VSMC Binding site
IFNγ LPS IFNγ + LPS GAS ISRE NFκB
1 Cxcl9* 82.2 4.0 2380.5 • – •
2 F830016B08Rik* 1272.1 6.4 2306.6 • • •
3 Gm4841* 1087.3 9.0 1650.3 • • •
4 Nos2* 1.8 90.9 933.3 • • •
5 BC023105* 600.8 19.9 909.4 – – –
6 Gbp4* 304.3 16.4 795.8 • • •
7 Iigp1* 687.7 9.2 779.3 • • –
8 Ubd* 95.6 5.8 655.1 • • •
9 Gbp10* 315.9 21.1 588.2 • • •
10 Gbp9* 304.8 22.9 586.1 – • •
11 Gbp6* 266.1 23.5 555.3 • • •
12 Serpina3f* 200.1 13.0 529.6 • • •
13 Gbp11* 302.3 13.6 482.7 • • –
14 Gm12250 502.9 3.6 477.8 • • –
15 Gbp8* 215.5 12.9 405.2 • • •
16 Ciita 704.4 2.0 376.5 • • •
17 Cxcl10* 49.8 4.6 364.9 • • •
18 Gbp1* 295.0 17.5 364.8 – • –
19 Gja4* 82.3 1.6 329.9 • • •
20 Gm4951* 300.1 6.9 327.2 • – –
21 Batf2* 191.4 3.1 298.4 • • –
22 Lcn2* 3.8 36.5 289.2 – – •
23 Gbp2* 219.7 13.4 284.4 – • •
24 Igtp 328.8 5.3 274.1 • • –
25 Tgtp2 261.9 2.6 262.5 • • –
26 Gm5970* 183.1 2.3 236.1 – – –
27 Ccl8* 115.8 18.6 231.4 • • •
28 Tgtp1* 216.7 2.4 222.4 • • •
29 Gbp5* 67.7 9.2 211.5 • • •
30 Saa3* 4.2 66.6 196.1 • – •
Gene expression levels were presented as FC relative to control in VSMCs. Signal Integrated genes (FC IFNγ + LPS > FC IFNγ + FC LPS) were marked by an asterisk (*). Overlapping
genes between IFNγ + LPS- and IFNα + LPS-induced commonly up-regulated genes (Table 1A) were color-coded by blue. Presence of GAS, ISRE, or NFκB binding sites in the
promoters of listed genes was indicated by a dot (•).
mechanism is involved in the interaction between IFNα and LPS
or IFNγ and LPS in VSMC, in analogy to M8 and DC.
Genome-wide Binding of STAT1 and p65 to
IFNα + LPS and IFNγ + LPS Regulated
Genes Is Mediated Through Comparable
Single and Co-binding Modes
To obtain further insight in the mechanism of priming-induced
SI between IFNs and LPS inVSMC, we characterized the genome-
wide binding of STAT1 and NFκB (p65) to the regulatory
regions of IFNα+ LPS and IFNγ+ LPS commonly up-regulated
genes. Thus, we performed ChIP-seq on chromatin from VSMC
exposed to IFNα (8 h), IFNγ (8 h), or LPS (4 h) alone, or
combined treatment (IFNα 8 h+ LPS 4 h; IFNγ 8 h+ LPS 4 h).
Clustering analysis of the genomic regions occupied by
STAT1 and/or p65 in response to single or combined treatments
(Figure 2A) are visualized as tag counts (blue signals) in the
RD plot. This analysis revealed that a subset of STAT1 and p65
binding regions (i.e., Cluster 7) were clearly co-occupied by these
transcription factors when combined treatments (IFNα + LPS
or IFNγ + LPS) were used, reflected by increased blue color
intensity on the graph (Figure 2A). However, other genomic
regions correlated with binding of STAT1 or p65 alone [i.e.,
Cluster C1, C9 (p65 only), Cluster C2 and C8 (STAT1 only)].
Subsequently, using HOMER software, GAS, ISRE, and NFκB
consensus motifs (Figures S1A–C) were re-mapped to STAT1
and p65 binding regions and compared to the lists of 579
IFNα + LPS and 536 IFNγ + LPS commonly up-regulated
genes (Figure 2B). Genomic binding analysis indicated that the
STAT1 (GAS or ISRE) and p65 (NFκB) binding sites were
primarily located in distant intergenic regions and intronic
regions, while to a lesser extent in promoters, of IFNα +
LPS- and IFNγ + LPS-responsive genes (Figure 2B). A similar
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FIGURE 2 | Genome-wide role of STAT1 and p65 in transcriptional regulation of commonly up-regulated IFNα + LPS- and IFNγ + LPS-induced genes. (A) RD
heatmaps for ChIP-seq peaks clustered (k-means clustering) based on STAT1 and p65 binding pattern across control, IFNα (8 h), IFNγ (8 h), LPS (4 h), IFNα (8 h) +
LPS (4 h), IFNγ (8 h) + LPS (4 h) treatment conditions in VSMC. Identified clusters are marked as Cluster (C) 1–10. (B) Global distribution of STAT1 (GAS and ISRE)
and p65 (NFκB) occupied binding sites (from ChIP-seq) in 7 genomic locations (color-coded with the mapping provided in the legend): promoter/TSS (−1 kb to +100
bp), introns, intergenic, exon, 5′ UTR, 3′ UTR, and TTS. Re-mapped motifs distribution was plotted by the percentage of total number of occupied GAS, ISRE, and
NFκB binding sites present in the regulatory regions of commonly up-regulated IFNα (8 h) + LPS (4 h)- and IFNγ (8 h) + LPS (4 h)-induced genes. (C) Representation
of STAT1 and p65 occupied binding sites identified by ChIP-seq, representing “single” modes (STAT1 binding to GAS and/or ISRE; p65 binding to NFκB) or
“co-binding” modes (STAT1 binding to GAS and/or ISRE together with p65 to NFκB). Table depict number of the genes within each STAT1/p65 binding mode among
IFNα (8 h) + LPS (4 h)- and IFNγ (8 h) + LPS (4 h)-induced genes together with percentage overlap between the two treatment conditions.
distribution could be observed for the location of STAT1-NFκB
co-binding sites (Figure 2B), which is in agreement with the
above presented promoter analysis (Figure 1F), and predict the
presence of multiple STAT1 and NFκB binding sites in the
promoters of the IFNα + LPS and IFNγ + LPS commonly
up-regulated genes.
By next comparing genome-wide binding results for STAT1
and p65 after VSMC stimulation with IFNα + LPS and IFNγ
+ LPS, we could identify different groups of genes, where
STAT1 bound to consensus ISRE and/or GAS sites and p65 to
NFκB sites. These binding sites were present in gene regulatory
regions and existed in different combinations. As such we
could distinguish genes which contained solitary ISRE, GAS,
or NFκB sites, but also GAS-ISRE, ISRE-NFκB, GAS-NFκB, or
GAS-ISRE-NFκB sites. Based on these gene groups we further
defined STAT1 and p65 binding modes, including “single”
(STAT1 binding to GAS and/or ISRE; p65 to NFκB) or “co-
binding” (STAT1 binding to GAS and/or ISRE + p65 to NFκB)
(Figure 2C). Among IFNα+ LPS-induced genes, 6 GAS-only, 81
ISRE-only, 85 NFκB-only, and 51 GAS-ISRE containing genes,
were identified. In case of IFNγ + LPS stimulation, we could
distinguish 17 GAS-only, 45 ISRE-only, 28 NFκB-only, and 53
GAS-ISRE containing genes. Together they reflect the “single”
binding mode. In addition, IFNα + LPS- and IFNγ + LPS-
induced genes also included STAT1-p65 “co-binding” genes,
which could be divided in GAS-NFκB: 23 and 40 genes, ISRE-
NFκB: 94 and 59 genes and GAS-ISRE-NFκB genes: 99 and 178
genes, respectively.
Comparison of the different binding modes between IFNα
+ LPS- and IFNγ + LPS-induced conditions, identified a
substantial overlap for NFκB-only (15.9%), GAS-only (13%),
and ISRE-only (29.4%) containing genes from the “single” mode
(Figure 2C). As reported previously, both IFN-I and IFN-II
direct GAF complexes to GAS motifs, what is reflected by 13%
overlap between the two conditions within GAS-only mode in
our study. Yet 29.4% overlap found between IFNα- and IFNγ-
activated genes within ISRE-only mode was very surprising, since
limited evidence exists for a role of ISGF3 in IFN-II-driven
gene expression. Likewise, this overlap could be observed for
GAS-ISRE (32.7%), GAS-NFκB (11.1%), ISRE-NFκB (21.6%),
and GAS-ISRE-NFκB genes (29.6%) from the “co-binding”
mode (Figure 2C).
Collectively, this suggests that a common genome-wide SI
mechanism exists, which involves combinatorial actions of ISGF3
or GAF with NFκB on ISRE/NFκB or GAS/NFκB binding sites,
in the interaction of IFNα and LPS or IFNγ and LPS in VSMC.
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STAT1 as Part of ISGF3 Regulates
Transcription of ISRE-containing Genes in
Response to IFN-I and IFN-II
A striking observation after comparing IFNα + LPS and IFNγ
+ LPS commonly up-regulated genes was the high number of
overlapping STAT1-binding ISRE-containing genes (Figure 2C).
Close examination of the 45 ISRE-only and 59 ISRE-NFκB
containing genes, up-regulated after stimulation with IFNγ +
LPS (Figure 2C), identified the presence of an ISRE, but no
GAS binding site, occupied by STAT1 in the regulatory regions
of these genes. Moreover, STAT1 binding could already be
observed after treatment of VSMC with IFNγ alone (data not
shown), correlating with their transcriptional activity. Among
these genes were classical ISRE-containing genes, from which we
selected Ifit1, Mx2, Oas2, Cxcl10, and Irf7 (Figure 3A) to further
characterize the nature of this STAT1-dependent mechanism
in several experiments. All 5 genes were highly responsive to
IFNα and to a lesser extent to IFNγ, with Ifit1, Mx2, and
Cxcl10 being effected by SI after combined treatment with IFNα
+ LPS and IFNγ + LPS (Figure 3A). This correlated with
the slight increase in STAT1 and STAT2 phosphorylation in
response to both stimuli as compared to the individual ones
(Figure 3B). Ifit1, Mx2, Oas2, and Irf7 are examples of ISRE-
only genes, which is in agreement with a single STAT1-binding
peak (Figure 3D). In case of Cxcl10 two STAT1-binding peaks
were previously identified by Rauch et al., distal and proximal,
corresponding to a known ISRE-GAS composite site and a single
ISRE motif, respectively (9). Therefore, in this part of our study,
the single ISRE site present in the proximal region of the Cxcl10
promoter was chosen to further validate IFN-dependent STAT1
recruitment (Figure 3D). IGV genome browser views exhibited
binding of STAT1 to ISRE-containing regions of all of these genes
in VSMC, treated with IFNα, IFNγ, LPS, IFNα + LPS, and IFNγ
+ LPS (Figure 3D). STAT1 ChIP-seq results were further verified
by quantitative ChIP-PCR, which demonstrated a significant
enrichment of tSTAT1 recruitment to ISRE motifs present in the
promoters of Ifit1, Mx2, Oas2, Cxcl10, and Irf7 after stimulation
with both IFNα and IFNγ (Figure 3E). This coincided with
the binding of pSTAT1, which was significantly higher after
IFNγ treatment than after IFNα treatment and reflected STAT1
phosphorylation levels under these conditions (Figure 3E).
Similarly, we examined the potential binding of pSTAT2, tSTAT2,
and IRF9 under these conditions (Figures 3F,G, respectively).
It demonstrated increased recruitment of pSTAT2 to the ISRE-
containing promoters of Ifit1, Mx2, Oas2, Cxcl10, and Irf7
genes, after stimulation with IFNα and surprisingly with IFNγ
(Figure 3F). Like pSTAT1, the level of pSTAT2 enrichment was in
line with the STAT2 phosphorylation levels, which unexpectedly
could also be detected after IFNγ and IFNγ + LPS treatment
(Figure 3B). The binding of IRF9 showed a similar pattern as
that of pSTAT2 and corresponded to IRF9 expression levels
present in IFNα, IFNγ, and/or LPS treated cells (Figure 3B).
The simultaneous recruitment of pSTAT1, pSTAT2, and IRF9
after IFNα and IFNγ treatment, clearly correlated with the
involvement of ISGF3 in the transcriptional regulation of these
ISRE-containing genes in response to both types of IFN. Indeed,
co-IP of IRF9 with STAT1 and STAT2 in IFNα and IFNγ-
treated VSMC corroborated this observation (Figure 3C). The
expression pattern of these genes closely mirrored the binding
pattern of pSTAT2 and IRF9, being higher after IFNα treatment
in comparison to IFNγ treatment. Interestingly, the binding
of STAT1 displayed an opposite pattern (higher after IFNγ
treatment than after IFNα). This suggested the participation of
STAT1 in an additional ISRE-binding complex in IFNγ-treated
cells. Based on the high phosphorylation levels of STAT1 and
the increased expression of IRF9 under these conditions, this
complex could possibly consist of STAT1 homodimers together
with IRF9 (39).
Since IRF1 expression levels increased in IFNα, IFNγ, and/or
LPS treated VSMC (Figure 3B), we also tested the possible
involvement of a STAT1-IRF1 containing complex. Interestingly,
IRF1 was also recruited to these ISRE-containing genes after
stimulation with IFNγ, but only weakly upon IFNα treatment
(Figure 3H). The strongest IRF1 recruitment was noticed for
Ifit1 and Mx2, in comparison to Oas2, Cxcl10, and Irf7 gene
promoters. However, no interaction could be detected between
STAT1 and IRF1 under these conditions (Figure 3C), pointing
to a STAT1-independent role of IRF1 in the transcriptional
regulation of a selective group of ISRE-containing genes.
Our results are in agreement with the existence of a more
general mechanism in mouse primary VSMC, in which the IFNα
response of ISRE-containing genes is mainly driven by ISGF3.
In contrast, their IFNγ response is mediated by ISGF3 and
potentially by STAT1/IRF9.
Recruitment of STAT1 and p65 in Response
to IFNα + LPS or IFNγ + LPS Is Restricted
to GAS/NFκB or ISRE/NFκB Composite
Sites
Subsequently, we concentrated on the overlap of STAT1-p65
“co-binding” modes between IFNα + LPS- and IFNγ + LPS-
induced conditions. Interestingly, genome-wide these co-binding
sites occurred at a similar distance of not more than ∼200
bp (Figure 4A). First, we determined how many of the genes
which were assigned either to GAS-NFκB, ISRE-NFκB, or GAS-
ISRE-NFκB modes (Figure 2C) were affected by SI under these
conditions. We identified 170 of such genes up-regulated by
IFNα + LPS and 211 by IFNγ + LPS, of which 106 were in
common (Figure 4B). From this list of genes, we selected several
examples representing the three STAT1-p65 “co-binding” modes:
Serpina3i, Steap4, Irf1 (GAS-NFκB mode), Ccl5, Ifit1, Gbp6
(ISRE-NFκBmode), Cxcl10, Gbp7 (GAS-ISRE-NFκBmode). The
RNA-seq FC values, representing gene expression changes upon
treatment with IFNα, IFNγ, LPS, and IFNα + LPS, IFNγ +
LPS, are presented in Figure 4C. Indeed, all of these genes were
responsive to at least two single stimuli and affected by SI,
reflected by increased gene expression after combined treatment
with IFNα+ LPS or IFNγ+ LPS in comparison to the sum of the
single treatments (Figure 4C).
STAT1 and p65 ChIP-seq IGV genome browser views of these
pre-selected genes in response to IFNα + LPS and IFNγ +
LPS, encompass the different STAT1-p65 “co-binding” modes
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FIGURE 3 | STAT1, STAT2, IRF9, and IRF1 in transcriptional regulation of ISRE-containing genes under stimulation with IFN-I and IFN-II. (A) Gene expression values
(FC in comparison to control) for Ifit1, Mx2, Oas2, Cxcl10, and Irf7 genes, resulting from RNA-seq: VSMC untreated or treated with IFNα (8 h), IFNγ (8 h), LPS (4 h),
IFNα (8 h) + LPS (4 h), IFNγ (8 h) + LPS (4 h). (B) Western blot. Protein extracts were isolated from VSMC untreated or treated with IFNα (8 h), IFNγ (8 h), LPS (4 h),
IFNα (8 h) + LPS (4 h), IFNγ (8 h) + LPS (4 h). Levels of tSTAT1, pSTAT1, tSTAT2, pSTAT2, IRF1, IRF9, p65, and tubulin were assessed by Western blot. n = 3, one
representative blot is presented; Western blot quantification. Bars represent mean quantification of pSTAT1/tSTAT1 and pSTAT2/tSTAT2 ratio (normalized to tubulin).
Mean ± s.e.m., n = 3; (C) Co-IP. Protein extracts were isolated from VSMC untreated or treated with IFNα (8 h) and IFNγ (8 h), immunoprecipitated with IRF9 or IRF1
antibodies and analyzed by tSTAT1 and/or tSTAT2 Western blot. n = 3, one representative blot is presented. (D) Representative views of STAT1 ChIP-seq peaks
detected in the ISRE-containing promoters of Ifit1, Mx2, Oas2, Cxcl10, and Irf7 genes, in untreated or IFNα (8 h), IFNγ (8 h), LPS (4 h), IFNα (8 h) + LPS (4 h), IFNγ (8 h)
+ LPS (4 h)-stimulated VSMC. STAT1 peaks were mapped onto the mouse reference genome mm10 and visualized using the IGV genome browser. (E) VSMC were
untreated or treated with IFNα (8 h) and IFNγ (8 h) and ChIP-PCR validation of tSTAT1 and pSTAT1 binding to ISRE motif present in the promoters at Ifit1, Mx2, Oas2,
Cxcl10, and Irf7 genes was performed. Mean ± s.e.m., n = 2. Primers are listed in Table S2. ChIP-PCR. VSMC were untreated or treated with IFNα (8 h) and IFNγ
(8 h), chromatin was isolated and immunoprecipitated with (F) tSTAT2, pSTAT2, (G) IRF9 and (H) IRF1 antibodies, followed by ChIP-PCR analysis. Mean ± s.e.m., n =
2. Primers are listed in Table S2.
(Figure 4D). IGV tracks reveal the binding pattern of STAT1
and p65 to the promoters of Serpina3i, Steap4, Irf1 (GAS-NFκB
sites), Ccl5, Ifit1, Gbp6 (ISRE-NFκB sites), Cxcl10, Gbp7 (GAS-
ISRE-NFκB sites) genes, after stimulation with IFNα, IFNγ,
LPS, and combined treatments with IFNα + LPS or IFNγ +
LPS (Figure 4D). In case of Cxcl10 two STAT1-p65 co-binding
peaks could be observed (Figure 4D), distal and proximal,
corresponding to a known GAS-ISRE-NFκB composite site and
a combined ISRE-NFκB motif (9, 40). In this second part of our
study, the GAS-ISRE-NFκB composite site present in the distal
region of the Cxcl10 promoter was chosen to further validate
IFN-dependent STAT1 and p65 recruitment.
In conclusion, for the majority of these genes STAT1 and
p65 binding peaks were closely aligned in the co-bound gene
promoters, what further correlated with the close proximity of
GAS and NFκB or ISRE and NFκB binding sites. This close
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FIGURE 4 | Representatives of STAT1 and p65 “single” and “co-binding” modes. (A) Peak distribution plots showing distances between summits of STAT1 and the
closest p65 peak summits resulted from ChIP-seq in VSMC under IFNα (8 h) + LPS (4 h) and IFNγ (8 h) + LPS (4 h) treatment conditions. (B) Venn diagram showing
the intersection of 170 IFNα (8 h) + LPS (4 h)- and 211 IFNγ (8 h) + LPS (4 h)-activated SI genes resulting from RNA-seq. (C) Table presents gene expression values
(FC in comparison to control), resulting from RNA-seq experiment: VSMC treated with IFNα (8 h), IFNγ (8 h), LPS (4 h), IFNα (8 h) + LPS (4 h), IFNγ (8 h) + LPS (4 h) and
GAS-NFκB and ISRE-NFκB binding sites distance (bp) for selected genes representing identified STAT1 and p65 ’co-binding’ modes: GAS-NFκB: Serpina3i, Steap4,
Irf1; ISRE-NFκB: Ccl5, Ifit1, Gbp6; GAS-ISRE-NFκB: Cxcl10 and Gbp7; ISRE: Irf7; NFκB: Saa1. (D) Representative views of STAT1 and p65 ChIP-seq peaks (STAT1:
violet peaks, p65: dark blue peaks) identified in the regulatory regions of Serpina3i, Steap4, Irf1, Ccl5, Ifit1, Gbp6, Cxcl10, Gbp7, Irf7, and Saa1 genes, in untreated or
IFNα (8 h), IFNγ (8 h), LPS (4 h), IFNα (8 h) + LPS (4 h), IFNγ (8 h) + LPS (4 h)-stimulated VSMC. STAT1- and p65-binding peaks were mapped onto the mouse
reference genome mm10 and visualized using the IGV genome browser.
binding sites distribution may be a pre-requisite for effective
STAT1 and p65 collaboration.
STAT1 Recruitment to GAS/NFκB or
ISRE/NFκB Composite Sites Precedes p65
and Correlates With Elevated Transcription
of IFNα + LPS and IFNγ + LPS Regulated
Genes in VSMC
Validation experiments for STAT1 and p65 by quantitative ChIP-
PCR, using freshly isolated material (Figures 5A,B) confirmed
the binding pattern of both STAT1 and p65 as presented in
Figure 4D. It also supported the following conclusions. First, for
all genes, STAT1 and p65 binding peaks were closely aligned
in the promoters. This correlated with the close proximity of
GAS and NFκB or ISRE and NFκB binding sites (∼200 bp;
Figure 4C), which may be a pre-requisite for effective STAT1 and
p65 collaboration. Moreover, Tables 1A,B confirm the presence
of GAS, ISRE, and NFκB binding sites [indicated by a dot
(•)] in the promoters of 30 of the highest commonly up-
regulated genes by IFNγ + LPS and IFNα + LPS in VSMC. This
additionally emphasizes the observation that the availability of
multiple binding sites for these transcription factors within the
gene promoters may play a role in coordination of immediate and
robust gene transcriptional activation.
Second, although stimulation with both IFN-I and IFN-II
resulted in elevated levels of total STAT1 protein, but not for
total p65 (Figure 3B), for the majority of the genes the potency
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FIGURE 5 | STAT1 modulates increased p65 recruitment to GAS/NFκB or ISRE/NFκB composite sites. (A) ChIP-PCR of STAT1 at Serpina3i, Steap4, Irf1, Ccl5, Ifit1,
Gbp6, Cxcl10, and Gbp7 gene promoters (primers are listed in Table S2) in VSMC WT treated with IFNα (8 h), IFNγ (8 h), LPS (4 h), IFNα (8 h) + LPS (4 h), IFNγ (8 h) +
LPS (4 h). Mean ± s.e.m., n = 2. (B) ChIP-PCR of p65 at Serpina3i, Steap4, Irf1, Ccl5, Ifit1, Gbp6, Cxcl10, and Gbp7 gene promoters in VSMC WT treated with IFNα
(8 h), IFNγ (8 h), LPS (4 h), IFNα (8 h) + LPS (4 h), IFNγ (8 h) + LPS (4 h). Mean ± s.e.m., n = 2. (C) ChIP-PCR of p65 at Serpina3i, Steap4, Irf1, Ccl5, Ifit1, Gbp6,
Cxcl10, and Gbp7 gene promoters in VSMC STAT1 KO treated with IFNα (8 h), IFNγ (8 h), LPS (4 h), IFNα (8 h) + LPS (4 h), IFNγ (8 h) + LPS (4 h). Mean ± s.e.m.,
n = 2.
of STAT1 recruitment correlated with that of p65 binding.
Interestingly, this was not restricted to IFNα + LPS and IFNγ
+ LPS treatments, but also clearly visible after single treatments
with IFNα or IFNγ. In general, STAT1 and p65 binding after
IFNγ and IFNγ + LPS was stronger than after IFNα and
IFNα + LPS (Figures 5A,B). Third, increased p65 binding after
single treatments with IFNα or IFNγ could only be detected at
GAS/NFκB or ISRE/NFκB composite sites (Figure 4D), but not
at genes with solitary NFκB binding sequences (exemplified by
Saa1; Figure 4D).
Fourth, for all STAT1-p65 co-bound gene promoters except
Gbp6, we observed a moderate increase in the recruitment
of STAT1 after combined treatment with IFNγ + LPS in
comparison to IFNγ alone. Likewise, combined treatment with
IFNα + LPS resulted in slightly increased STAT1 binding in
comparison to IFNα single treatment (Figure 5A). Notably,
binding of STAT1 after IFNα treatment was significantly weaker
in comparison to IFNγ-induced STAT1 recruitment, likewise to
increased STAT1 recruitment after combined treatment. This
observation correlated with FC expression values of examined
STAT1-p65 “co-bound” genes (Figure 4C), which in general were
more responsive to IFNγ + LPS than to IFNα + LPS. The
same was true for p65, which recruitment, similar to STAT1
was increased after IFNα + LPS or IFNγ + LPS treatment
in comparison to single LPS stimulation yet to a much higher
extent (Figure 5B). In contrast, ChIP-PCR for p65 on chromatin
isolated from untreated, IFNα, IFNγ, LPS, IFNα + LPS, IFNγ +
LPS-treated STAT1 KOVSMC, for all genes resulted in abrogated
recruitment of p65 after single treatments with IFNα or IFNγ
(Figure 5C). Moreover, p65 binding remained unaltered after
combined treatments with IFNα + LPS or IFNγ + LPS in
comparison to LPS alone (Figure 5C).
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Together, these observations could point to a STAT1-
dependent role in the nearby recruitment of p65 upon
single IFNα or IFNγ treatment, via closely located
GAS and NFκB or ISRE and NFκB binding sites
in the promoters of SI genes. More important, this
STAT1-p65 co-binding was significantly increased upon
subsequent LPS exposure and resulted in amplified
transcriptional activity.
IFNα + LPS and IFNγ + LPS Induced SI
Correlates With Active Histone Marks and
Increased PolII Recruitment in a
STAT1-p65 Co-binding Dependent Manner
To understand in more detail the epigenetic changes that
coincide with STAT1 and p65 co-binding we investigated
the establishment of active histone marks at the Cxcl10 and
Gbp7 “co-binding” mode promoters. We observed increased
enrichment of H3K27Ac at these promoters in response to
IFNα, IFNγ, and LPS, which was further increased after IFNα +
LPS and IFNγ + LPS treatment (Figure 6A). As expected, the
binding pattern of the negative H3K27me3 mark was opposite
to that of H3K27Ac under the different treatment conditions
(Figure 6A). This could indicate that these genes harbor a
permissive chromatin conformation, which is positively affected
by IFNα + LPS and IFNγ + LPS stimulation. To address the
mechanism of increased transcription after STAT1 and p65 co-
binding we also analyzed the recruitment of PolII. As shown in
Figure 6A, the association of PolII with the Cxcl10 and Gbp7
promoters mirrored that of the H3K27Ac mark and pointed to
a STAT1-p65 co-binding dependent effect on histone acetylation
and transcriptional activity upon IFNα + LPS and IFNγ +
LPS treatment.
To further prove this, we analyzed the enrichment pattern
of these two histone marks and PolII at the promoters of
the “single” binding mode genes Irf7 (STAT1 only) and Saa1
(NFκB only) (Figures 4D, 6B). Indeed, H3K27Ac and PolII
binding to the Irf7 promoter showed an increase after IFNα,
IFNγ, and LPS treatment. The opposite was true for H3K27me3
binding (Figure 6C), whereas the binding patterns for H3K27Ac,
H3K27me3 and PolII did not significantly change after IFNα +
LPS or IFNγ + LPS induction (Figure 6C). This was in line with
STAT1 only binding, and no NFκB (Figures 4D, 6B), and the
lack of SI on transcriptional activity (Figure 4C). For the Saa1
promoter H3K27Ac associationwas not affected by IFNα or IFNγ
treatment, but increased to a similar extent after LPS, IFNα +
LPS, and IFNγ + LPS stimulation (Figure 6C). This coincided
with NFκB only binding, and no STAT1 (Figures 4D, 6B). A
similar, but only marginal LPS-mediated effect on abrogated
H3K27me3 binding could be observed for the Saa1 promoter
(Figure 6C). PolII recruitment to the Saa1 promoter exhibited
a similar LPS-dependent pattern as that of H3K27Ac, although
a slight increase was observed in response to IFNγ + LPS.
This correlated with transcriptional activity of Saa1, which was
substantially increased upon IFNα + LPS and IFNγ + LPS
stimulation as compared to single stimuli (Figure 4C).
Our results suggest that STAT1 and p65 bind to DNA
independently, yet in a sequential manner, directed by IFN-
I or IFN-II treatment followed by LPS stimulation. As such,
stimulation with IFNs results in robust STAT1 recruitment to
ISRE and/or GAS motifs in gene promoters and potentially
introduces chromatin modifications to increase NFκB binding to
closely located sites and enhance transcription.
DISCUSSION
Excessive immune and inflammatory responses, communicated
by immune, and vascular cells contribute to local inflammation
and vascular dysfunction, followed by atherosclerotic plaque
formation within the intima of the arterial wall. Priming-
induced SI of IFN-II, and possibly IFN-I, with TLR4 is a
common phenomenon in atheroma interacting immune cells
that modulates important aspects of inflammation, with STAT1
and NFκB being central mediators. Thus, IFN pre-treatment
(“priming”) followed by LPS stimulation leads to enhanced
transcriptional responses as compared to the individual stimuli.
To characterize themechanism of priming-induced IFNα+ LPS-
and IFNγ + LPS-dependent SI in vascular cells as compared
to immune cells, we performed a comprehensive genome-
wide analysis of mouse VSMC, M8, and DC in response to
IFNα, IFNγ, and/or LPS. Specifically, we aimed at providing
mechanistic insight in the cooperative binding of STAT1
complexes with NFκB to ISRE/NFκB and/or GAS/NFκB binding
sites in relation to transcription and how this is involved in the
overlap of IFN-I/LPS and IFN-II/LPS activated SI in VSMC.
First, we compared the gene expression profiles of the different
cell types exposed to the individual or combined stimuli, to
identify the commonly up-regulated genes as a result of the
interaction between IFNα and LPS or between IFNγ and LPS.
Generally, in all three cell types combined treatment with IFNα
+ LPS or IFNγ + LPS resulted in a synergistic increase in
gene expression as compared to single treatments, pointing to a
common effect of SI mediated by the different IFNs (Figure 1).
In agreement with the similar effect of SI mediated by the
different IFNs and LPS, we observed >64% overlap between
commonly up-regulated genes in response to IFNα + LPS
and IFNγ + LPS. GO analysis revealed functional overlap of
these genes connected to stress, immune and inflammatory
response, response to cytokine, regulation of cell proliferation
and migration, regulation of cell adhesion and chemotaxis,
cell death and apoptotic process, response to lipid, and ROS
metabolic process, all reflecting pro-inflammatory and pro-
atherogenic biological functions (Figure 1). Together this may be
a reflection of the partial overlap in activation of transcription
factor complexes and regulation of target gene expression by
IFN-I and IFN-II, which results in the execution of cell type-
common biological responses. Subsequent promoter analysis of
these genes indeed predicted the presence of either single GAS
sites or rather combinations of potential GAS-ISRE, GAS-NFκB,
or GAS-ISRE-NFκB binding motifs, with a similar binding site
distribution between IFNα + LPS and IFNγ + LPS treatment
conditions (Figure 1). In general, under these conditions ISRE
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FIGURE 6 | PolII and histone modification changes upon stimulation with IFNs and LPS at promoters of STAT1 and p65 “co-binding” and “single” modes
representatives. (A) ChIP-PCR of H3K27Ac, H3K27me3, and PolII at Cxcl10 and Gbp7 gene promoters (primers are listed in Table S2) in VSMC treated with IFNα
(8 h), IFNγ (8 h), LPS (4 h), IFNα (8 h) + LPS (4 h), IFNγ (8 h) + LPS (4 h). Mean ± s.e.m., n = 2. (B) ChIP-PCR of STAT1 and p65 at Irf7 and Saa1 gene promoters
(primers are listed in Table S2) in VSMC treated with IFNα (8 h), IFNγ (8 h), LPS (4 h), IFNα (8 h) + LPS (4 h), IFNγ (8 h) + LPS (4 h). Mean ± s.e.m., n = 2.
(C) ChIP-PCR of H3K27Ac, H3K27me3 and PolII at Irf7 and Saa1 gene promoters (primers are listed in Table S2) in VSMC treated with IFNα (8 h), IFNγ (8 h), LPS
(4 h), IFNα (8 h) + LPS (4 h), IFNγ (8 h) + LPS (4 h). Mean ± s.e.m., n = 2.
motifs correspond to binding of STAT1 and STAT2 (in the form
of ISGF3) and possibly different IRFs (IRF1, IRF7, IRF8, IRF9),
GASmotifs to that of STAT1 binding andNFκBmotifs to binding
of p65 and p50. Previously we revealed, that the promoters of
genes affected by the SI between IFNγ and LPS, like Cxcl9,
Cxcl10, and Nos2, which are also present among the highest
expressed common genes in the current study, contain STAT-
NFκB and IRF-NFκB modules or combinations of separate ISRE,
GAS or NFκB binding sites (20, 41). Together this suggested that
a common SI mechanism is involved in the interaction between
IFNα and LPS or IFNγ and LPS inVSMC,M8, andDC. Together
this suggested that although VSMC, M8, and DC perform cell
type specific functions in a healthy vessel, stimulation with
pro-inflammatory stimuli results in activation of a common SI
mechanism in the interaction between IFNα and LPS or IFNγ
and LPS.
To understand this mechanism of SI in more detail, we
characterized the genome-wide binding of STAT1 and NFκB
(p65) to the IFNα + LPS- and IFNγ + LPS commonly up-
regulated genes. Using ChIP-seq on chromatin from VSMC,
STAT1 and p65 bound IFNα + LPS and IFNγ + LPS up-
regulated genes were identified, containing GAS, ISRE, or NFκB
binding motifs located in promoter regions, but also to up-
and downstream genomic regions. Obviously, the interaction
between IFNα + LPS and IFNγ + LPS increased the genome-
wide number of STAT1 and p65 binding sites (as compared to
individual treatments), correlating with the observed SI effect
on transcription under these conditions (data not shown). The
vast majority of STAT1 and p65 binding events localized outside
gene promoters (Figure 2). This correlates with the general view
of genome-wide occupancy of individual transcription factors,
which regulate gene expression through integrated action of
proximal and distal cis-regulatory elements [reviewed in (42)],
the latter being functionally related with cell type-specific gene
expression (43). This binding site distribution coincided with
other studies. For example, in IFNγ stimulated HeLa S3 cells,
Satoh et al. provided evidence for the presence of STAT1 binding
GAS motifs in intronic regions (44), while others observed
that ∼50% of the total STAT1-occupied binding sites were
intragenic and 25% intergenic (45). Similar observations have
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been reported for NFκB. As shown for LPS-treated THP1 cells,
a significant proportion of genome-wide NFκB binding sites
are located in proximal upstream promoter regions (26%),
whereas an even greater proportion of p65 binding sites were
found to be located within introns (38%) (46). On the other
hand, in TNFα-treated HeLa cells, location analysis revealed
that the p65-binding sites are mainly intragenic (46%) and
only 7% are located in promoters, in agreement with previous
studies (47). The function of the majority of distal STAT1 and
p65 binding sites remains largely unknown. Nevertheless, it
predicts the presence of a common regulatory mechanism of ISG
transcriptional regulation.
Focusing on binding motifs in gene promoters, we could
distinguish different STAT1 and p65 binding modes, including
“single” (STAT1 binding to GAS and/or ISRE; p65 to NFκB)
or “co-binding” (STAT1 binding to GAS and/or ISRE + p65 to
NFκB) (Figure 2). Comparison of the different binding modes
between IFNα + LPS and IFNγ + LPS induced conditions,
identified a substantial overlap for NFκB-only (15.9%), GAS-only
(13%), and ISRE-only (29.4%) containing genes from the single
mode. Likewise, this overlap could be observed for GAS-ISRE
(32.7%), GAS-NFκB (11.1%), ISRE-NFκB (21.6%), and GAS-
ISRE-NFκB genes (29.6%) from the co-binding mode. A more
detailed comparison of IFNα+ LPS and IFNγ+ LPS commonly
up-regulated ISRE-containing genes identified STAT1 binding to
these ISRE sites in response to IFNα and, unexpectedly to IFNγ
(Figure 2). More important, this STAT1 DNA binding clearly
corresponded to transcriptional activity in VSMC, as well as in
M8 and DC. Among these genes were many classical ISRE-
containing genes, including Ifit1, Mx2, Oas2, Irf7, and Cxcl10,
which were highly responsive to IFNα and to a lesser extent
to IFNγ (Figure 3A). All five genes were highly responsive to
IFNα and to a lesser extent to IFNγ, with Ifit1, Mx2, and Cxcl10
being effected by SI after combined treatment with IFNα + LPS
and IFNγ + LPS (Figure 3A). This correlated with the slight
increase in STAT1 and STAT2 phosphorylation in response to
both stimuli as compared to the individual ones (Figure 3B). The
simultaneous recruitment of pSTAT1, pSTAT2, and IRF9 after
IFNα and IFNγ treatment, clearly was in agreement with the
involvement of ISGF3 in the transcriptional regulation of these
ISRE-containing genes in response to both types of IFN. The
expression pattern of these genes closely mirrored the binding
pattern of pSTAT2 and IRF9 and reflected the phosphorylation
level of STAT2 and expression of IRF9, being higher after IFNα
treatment than after IFNγ treatment.
In support of a direct role for STAT2 in the IFNγ response,
its tyrosine phosphorylation was reported in a study using IFNγ-
treated wild-type mouse primary embryonic fibroblasts that
caused the formation of ISGF3 (8). This was in agreement with
observations made from the same group, in which mice lacking
IRF9 are impaired not only in their type I IFN response, but
also in their IFNγ-induced ISRE-dependent gene expression (48).
Similar observations were made by others in MEFs, in which
STAT2 phosphorylation was essential for the antiviral potency
of IFNγ (49). Together, this revealed the existence of an ISGF3-
dependentmechanism bywhich IFN-I and IFN-II can commonly
elicit antiviral activities.
The opposite binding pattern of pSTAT1 (higher after
IFNγ treatment than after IFNα; Figure 3), as compared to
pSTAT2 and IRF9, suggested the participation of STAT1 in an
additional ISRE-binding complex in IFNγ-treated cells. Based
on the high phosphorylation levels of STAT1 and the increased
expression of IRF9 under these conditions, we propose that this
complex consists of STAT1 homodimers together with IRF9.
The first evidence for STAT1- and IRF9-dependent and STAT2-
independent transcriptional regulation of IFNγ-induced gene
expression was reported for Ifit2, a classical ISRE-regulated gene
(39) and CXCL10 (50). More recently a role for STAT1/IRF9
in the regulation of the latter gene was studied in the context
of a murine colitis model. Molecular analysis in M8 confirmed
that STAT1/IRF9 complexes form in response to IFNγ and
associate with ISRE sequences of enhancer regions 1 and 2 of
the Cxcl10 gene promoter (9). In the same study, the authors
observed that the expression of IRF7 and DDX58, two other
known ISRE-containing genes, depended on STAT1 and IRF9 as
well as on STAT2 for their response to IFNγ pointing to a role
of ISGF3 instead of STAT1/IRF9. As such they suggested that
ISRE-containing promoters could potentially select STAT1/IRF9
complexes either with or without the STAT2 subunit for the
cellular response to IFNγ. However, in the VSMC that we
use in our study we cannot provide direct proof for a role
of the STAT1/IRF9 complex in IFNγ-mediated responses in
addition to ISGF3. Further experiments in VSMC from STAT2
and IRF9 KO mice will be needed to validate this assumption.
Interestingly, IRF1 was also recruited to these ISRE-containing
genes after stimulation with IFNγ, but only weakly upon IFNα
treatment (Figure 3). Since no interaction could be detected
between STAT1 and IRF1 under these conditions (Figure 3),
a STAT1-independent role of IRF1 in the transcriptional
regulation of a selective group of ISRE-containing genes can be
proposed. This was in contrast to the direct interaction between
unphosphorylated STAT1 and IRF1, which was detected in U3A
cells overexpressing STAT1 tyrosine 701 mutant and proposed to
mediate constitutive LMP2 gene expression (51).
Our results are in agreement with the existence of a more
general mechanism in mouse primary VSMC, in which ISGF3
and possibly STAT1/IRF9 regulate expression of IFNγ-responsive
ISRE-containing genes. Together with STAT1 homodimers
binding GAS, this provides an additional twist to the canonical
IFNγ signaling pathway, which could explain some of the
overlapping responses to IFNα and IFNy in these cells (Figure 7).
Based on the overlapping expression patterns of these genes in
VSMC, M8, and DC and the above described findings in M8,
it is tempting to speculate that the IFNα response of ISRE-
containing genes in all three cell types is mainly driven by
ISGF3. In contrast, their IFNγ response is mediated by ISGF3
and potentially by STAT1/IRF9 (Figure 7). In the latter case
a mechanism of competition could be envisioned or selective
binding, depending on the ISRE sequence.
To further understand the mechanism of cooperative
involvement of STAT1 with NFκB in SI mediated by the
interaction of IFNα and LPS or IFNγ and LPS, we next
concentrated on the overlap of STAT1-p65 co-binding modes.
Therefore, we analyzed in more detail STAT1 and p65 binding
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FIGURE 7 | Model describing transcriptional regulation of Signal Integrated genes by STAT1-mediated preceding of p65 and PolII to acetylated GAS/NFκB or
ISRE/NFκB composite sites. 1st wave of stimulation: After initial cell exposure to IFNα or IFNγ, receptors dimerize, and facilitate transphosphorylation of
receptor-bound JAK1/TYK2 kinases for IFNα and JAK1/JAK2 kinases for IFNγ. Next STAT proteins are recruited, phosphorylated and dimerized, either in a form of
ISGF3 complex (STAT1-STAT2 together with IRF9), GAF (STAT1 homodimers) or STAT1/IRF9 complex. Activated transcription factors supply a platform for 2nd wave
of stimulation: LPS stimulates TLR4 receptor associated with adapter molecules MyD88 and TRAM and activates NFκB, as well as STAT1-containing transcriptional
complexes. IFNα stimulation results in recruitment of ISGF3 to ISRE sites and GAF to GAS sites present in ISGs promoters. IFNγ initiates binding of GAF to GAS sites
as well as ISGF3 and possibly STAT1/IRF9 to ISRE elements. Initial binding of STAT1-containing complexes followed by subsequent p65-p50 heterodimers binding
(indicated by a violet curved arrow) to NFκB sites closely spaced to ISRE and GAS sites (∼200 bp), together results in histone acetylation enrichment and PolII
recruitment to ISG promoters. For a detailed explanation, see the text.
patterns in 170 IFNα + LPS and 211 IFNγ + LPS up-regulated
genes which were commonly affected by SI in the three cell types
(Figure 4). Strikingly, for the majority of these genes STAT1 and
p65 binding peaks were closely aligned in the co-bound gene
promoters, what further correlated with the close proximity of
GAS and NFκB (41–234 bp) or ISRE and NFκB (38–264 bp)
binding sites (Figure 4). This close binding sites distribution may
be a pre-requisite for effective STAT1 and p65 collaboration.
A similar organization of closely located ISRE and NFκB sites,
within ∼50 bp proximity, was reported for IRF3 and NFκB co-
occupancy to control Sendai virus-induced gene activation (52).
Also in IFNγ-treated cells in genome-wide studies co-binding
of STAT1 and IRF1 occurred at closely located GAS and ISRE
sites (6, 53).
Stimuli-induced binding of two different transcription factors
to closely spaced DNA motifs, could assume occurrence of direct
protein-protein interactions, which if exceeding >20 bp would
have to involve DNA looping (54). Indeed, STAT1 and NFκB
have been shown to directly cooperate in several studies (55,
56). On the other hand, although combined action of STAT1
and NFκB was reported to be pivotal for Cxcl9, IP-10, Becn1,
and NOS2 gene expression regulation, no direct protein-protein
interaction of these transcription factors was observed (40, 57–
59). Similarly, by performing co-IP experiments on protein
extracts isolated from IFNα + LPS and IFNγ + LPS-treated
VSMC, we were not able to detect direct interaction between
STAT1 and p65 protein (data not shown). Further examination
of the STAT1-p65 co-binding modes unraveled the involvement
of a STAT1-dependent role in the nearby recruitment of p65
via closely located GAS-NFκB or ISRE-NFκB binding sites.
IFNγ and to a lesser extent IFNα induced STAT1 binding
to gene promoters containing either GAS-NFκB (Serpina3i,
Steap4, Irf1), ISRE-NFκB (Ccl5, Ifit1, Gbp6), or GAS-ISRE-
NFκB (Cxcl10, Gbp7) motifs. Much weaker STAT1 recruitment
was also detected upon LPS stimulation, which correlated with
the fact that transcriptional activation of SI genes under these
conditions is primarily driven by IFNs (Tables 1A,B; Figures 4,
5). Interestingly, STAT1 recruitment to these different genes
coincided with that of p65 binding, already upon IFNα or IFNγ
treatment. This elevated p65 binding after single treatments with
IFNα or IFNγ could not be detected at genes with solitary NFκB
binding sequences (Figure 4). More important, subsequent LPS
exposure resulted in increased STAT1-p65 co-binding, mainly
driven by enhanced p65 recruitment, which correlated with
histone acetylation, PolII recruitment and amplified target gene
transcription in a STAT1-p65 co-bound dependent manner. In
general, STAT1 and p65 binding after IFNγ and IFNγ + LPS
was stronger than after IFNα and IFNα + LPS (Figure 5). The
fact that we were not able to detect direct STAT1-p65 protein-
protein interaction under studied treatment conditions in VSMC
(data not shown), we postulate that STAT1 and p65 bind to
DNA independently, yet in a sequential manner, directed by IFN-
I or IFN-II treatment followed by LPS stimulation. As such,
stimulation with IFNs results in robust STAT1 recruitment to
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ISRE and/or GAS motifs in gene promoters and potentially
introduces chromatin modifications to increase NFκB binding to
closely located sites.
Co-binding of STAT1 and NFκB has been studied in the
context of bacterial infection. For example, sequential and
cooperative contributions of NFκB preceding ISGF3, without
direct protein-protein interaction, were shown to be involved
in the transcriptional induction of the Nos2 and Il-6 genes in
M8 infected with the intracellular bacterial pathogen Listeria
monocytogenes. In this context, NFκB acted as the major
signal stimulated by TLR4 that introduced epigenetic marks
to produce transcription friendly chromatin and enhanced
subsequent recruitment of ISGF3, as the main signal from
subsequent IFNβ production and action. This co-binding of
NFκB followed by ISGF3, in combination with PolII, was
a prerequisite for productive elongation of Nos2 and Il-6
mRNA (13, 60). Likewise, Wort et al. observed that combined
stimulation of primary HPASM cells with TNFα and IFNγ
correlated with both increased histone H4 acetylation at distinct
NFκB sites and PolII recruitment to the PreproET-1 promoter
region (61). Others showed that in IL-10 and LPS-treated
phagocytes, STAT3 favored NFκB recruitment to the IL-1ra
gene promoter due to its increased acetylation (62). A more
comprehensive genome-wide co-binding study of IRF3 and
NFκB revealed a mechanism of virus-induced transcriptional
activation, in which IRF3 was able to organize promoter-
specific recruitment of PolII and NFκB provided the ability
to stimulate its efficient and processive elongation (52). On
the other hand, Giorgetti et al. demonstrated p65 ability
to additively recruit PolII to multiple κB sites containing
gene promoters, resulting in elevated gene transcriptional
activation (63). In case of IFNγ priming, a synergy mechanism
was described, whereby IFNγ created a primed chromatin
environment that sustained occupancy of STAT1, IRF1 and
associated histone acetylation at pre-selected target genes. This
greatly increased and prolonged recruitment of subsequent
TLR4-induced transcription factors, including NFκB, and PolII
to gene promoters and enhancers (64).
Based on these models our results are predictive of the
following mechanism of STAT1-NFκB co-binding involved in
the SI of IFN-I and IFN-II with TLR4 in VSMC, M8, and
DC (Figure 7). In the first step, IFN-I activated STAT1 is
recruited to closely located ISRE-NFκB or GAS-NFκB binding
sites in the form of ISGF3 or GAF, respectively. Likewise, IFNγ
stimulates the binding of the STAT1-complexes ISGF3 (and
possibly STAT1/IRF9) and GAF to these respective sites. This
first wave of STAT1 binding introduces chromatin modifications
and initiates subsequent p65-p50 recruitment to adjacent (∼200
bp) NFκB sites in response to IFNγ and to a lesser extent
after IFNα treatment, which correlates with STAT1-binding
potency and levels of transcription. The second step, which
is mediated by subsequent LPS stimulation, increases STAT1-
p65 co-binding to these different composite sites and is mainly
driven by enhanced p65-p50 dimer formation and recruitment.
This coincides with histone acetylation, PolII recruitment and
amplified transcription of IFNα + LPS and IFNγ + LPS up-
regulated genes, which in general is stronger after IFNγ + LPS
than after IFNα + LPS (Figure 7). In case of genes harboring
GAS-ISRE-NFκB composite sites, similar but more complex
mechanisms of canonical and non-canonical STAT1 complexes
in response to IFN-I or IFN-II combined with LPS-activated
NFκB are probably involved.
Thus, transcription factor complexes activated by IFN-I or
IFN-II together with LPS, including GAF, ISGF3, STAT1/IRF9,
and p65-p50 heterodimers provide a platform for robust
transcriptional activation of pro-inflammatory genes. Moreover,
our model offer for the first time an explanation for the
comparable effects of IFNα or IFNγ priming on TLR4-induced
activation in vascular and immune cells, which correlates with
the important roles of both IFN types in vascular inflammation
and atherosclerosis progression. However, we realize that this is
just a predictive model and we cannot rule out the involvement of
other STAT1-containing transcription factor complexes or IRFs.
Moreover, further investigation will be required to obtain insight
in the mechanism of STAT1-dependent NFκB recruitment and
subsequent transcriptional regulation under SI, involved in gene-
specific scenarios.
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